Lease Agreements in the Pharmaceuticals Industry

870 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (2 contracts)
ACELRX PHARMACEUTICALS INC (5)
Acer Therapeutics Inc. (7)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (4)
Adamis Pharmaceuticals Corp (4)
ADIAL PHARMACEUTICALS, INC. (1)
Aegerion Pharmaceuticals, Inc. (9)
Aerpio Pharmaceuticals, Inc. (3)
AGILE THERAPEUTICS INC (5)
Akorn (3)
ALDER BIOPHARMACEUTICALS INC (5)
Alexza Pharmaceuticals Inc. (1)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (2)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (9)
Amag Pharmaceuticals (10)
AmeriCann, Inc. (6)
Ampio Pharmaceuticals, Inc. (3)
AMYLIN PHARMACEUTICALS INC (2)
Amylyx Pharmaceuticals, Inc. (1)
Anacor Pharmaceuticals, Inc. (4)
ANADYS PHARMACEUTICALS INC (2)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (8)
Anthera Pharmaceuticals Inc (2)
APP Pharmaceuticals, Inc. (5)
Aquestive Therapeutics, Inc. (1)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (2)
ARIAD PHARMACEUTICALS INC (8)
ARVINAS, INC. (10)
Assertio Therapeutics, Inc (12)
Atea Pharmaceuticals, Inc. (3)
Athira Pharma, Inc. (2)
Auspex Pharmaceuticals, Inc. (5)
AUXILIUM PHARMACEUTICALS INC (3)
AVADEL PHARMACEUTICALS PLC (3)
AVANIR PHARMACEUTICALS, INC. (8)
AYTU BIOSCIENCE, INC (9)
BARR PHARMACEUTICALS INC (1)
Barrel Energy Inc. (1)
BioNumerik Pharmaceuticals, Inc. (2)
BioPharmX Corp (6)
Blue Water Acquisition Corp. (1)
BODY & MIND INC. (3)
Bohai Pharmaceuticals Group, Inc. (1)
CADENCE PHARMACEUTICALS INC (3)
Canbiola, Inc. (4)
CANNAPHARMARX, INC. (1)
Cara Therapeutics, Inc. (3)
CASSAVA SCIENCES INC (6)
Celator Pharmaceuticals Inc (2)
Cerecor Inc. (2)
CHIASMA, INC (7)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
CHINA PHARMA HOLDINGS, INC. (2)
Clearside Biomedical, Inc. (2)
CLS Holdings USA, Inc. (10)
COGNITION THERAPEUTICS INC (4)
COLLEGIUM PHARMACEUTICAL, INC (4)
Corcept Therapeutics Incorporated (11)
COSMO VENTURES INC (1)
CUBIST PHARMACEUTICALS INC (7)
CUMBERLAND PHARMACEUTICALS INC (8)
Cure Pharmaceutical Holding Corp. (1)
CymaBay Therapeutics, Inc. (4)
Cyteir Therapeutics, Inc. (3)
DiCE MOLECULES HOLDINGS, LLC (4)
Dova Pharmaceuticals Inc. (3)
DURECT CORP (21)
Edgewise Therapeutics, Inc. (1)
Egalet Corp (1)
Elixir Pharmaceuticals, Inc. (3)
Eloxx Pharmaceuticals, Inc. (5)
ENCYSIVE PHARMACEUTICALS INC (1)
EPIX Pharmaceuticals, Inc. (6)
Evofem Biosciences, Inc. (6)
Evoke Pharma Inc (8)
Evolus, Inc. (3)
Exactus, Inc. (3)
EyePoint Pharmaceuticals, Inc. (6)
EYETECH PHARMACEUTICALS INC (4)
Foamix Pharmaceuticals Ltd. (4)
Fulcrum Therapeutics, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
GRAYBUG VISION, INC. (2)
GUILFORD PHARMACEUTICALS INC (2)
HARROW HEALTH, INC. (1)
Haymaker Acquisition Corp. III (1)
Horizon Pharma plc (9)
IDENIX PHARMACEUTICALS INC (10)
Ikena Oncology, Inc. (1)
IMAGING3 INC (1)
IMARA Inc. (3)
INNOVATE BIOPHARMACEUTICALS, INC. (1)
Innoviva, Inc. (5)
INSPIRE PHARMACEUTICALS INC (4)
Intersect ENT, Inc. (4)
ISTA PHARMACEUTICALS INC (5)
Jaguar Health, Inc. (10)
JAVELIN PHARMACEUTICALS, INC (2)
Jazz Pharmaceuticals plc (7)
JUNIPER PHARMACEUTICALS INC (2)
Jushi Holdings Inc. (10)
Kala Pharmaceuticals, Inc. (2)
Kaleido Biosciences, Inc. (2)
Kaya Holdings, Inc. (5)
KEMPHARM, INC (4)
Lev Pharmaceuticals Inc (1)
Level Brands, Inc. (6)
Lexaria Bioscience Corp. (2)
LIPELLA PHARMACEUTICALS INC (4)
Lipocine Inc. (2)
Liquidia Technologies Inc (2)
Lumena Pharmaceuticals, Inc. (1)
Lyra Therapeutics, Inc. (3)
MAP Pharmaceuticals, Inc. (7)
MARINUS PHARMACEUTICALS INC (2)
MAXIM PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (1)
Menlo Therapeutics Inc. (2)
MICROCHANNEL TECHNOLOGIES CORP (7)
MiddleBrook Pharmaceuticals, Inc. (2)
MILLENNIUM PHARMACEUTICALS INC (1)
MIRA PHARMACEUTICALS, INC. (1)
MJ BIOTECH, INC. (1)
MJ Holdings, Inc. (6)
Molecular Insight Pharmaceuticals, Inc. (6)
MYnd Analytics, Inc. (2)
MyoKardia Inc (4)
Nabriva Therapeutics plc (2)
NEKTAR THERAPEUTICS (3)
Neuralstem, Inc. (2)
NEW RIVER PHARMACEUTICALS INC (8)
NGM BIOPHARMACEUTICALS INC (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (7)
Novan, Inc. (7)
NPS PHARMACEUTICALS INC (8)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (5)
OMEROS CORP (18)
Omthera Pharmaceuticals, Inc. (1)
OncoMed Pharmaceuticals Inc (4)
One World Pharma, Inc. (5)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (5)
OSCIENT PHARMACEUTICALS CORP (1)
OTONOMY, INC. (4)
Pacira Pharmaceuticals, Inc. (3)
Panacea Acquisition Corp (1)
PANACOS PHARMACEUTICALS, INC. (3)
Paratek Pharmaceuticals, Inc. (18)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (3)
Planet 13 Holdings Inc. (1)
PLIANT THERAPEUTICS, INC. (2)
PLx Pharma Inc. (5)
PONIARD PHARMACEUTICALS, INC. (5)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (5)
Prestige Brands Holdings Inc (2)
Processa Pharmaceuticals, Inc. (1)
Profile Solutions, Inc. (1)
ProPhase Labs, Inc. (3)
Pulmatrix, Inc. (1)
QUARK PHARMACEUTICALS INC (4)
Ra Pharmaceuticals, Inc. (1)
Rain Therapeutics Inc. (4)
Rani Therapeutics Holdings, Inc. (1)
REATA PHARMACEUTICALS INC (6)
Recro Pharma, Inc. (1)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (2)
RespireRx Pharmaceuticals Inc. (2)
resTORbio, Inc. (16)
Revance Therapeutics, Inc. (7)
Rib-X Pharmaceuticals, Inc. (1)
ROCK CREEK PHARMACEUTICALS, INC. (1)
SALIX PHARMACEUTICALS LTD (4)
SANCILIO PHARMACEUTICALS COMPANY, INC. (3)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (2)
scPharmaceuticals Inc. (3)
SenesTech, Inc. (5)
SHAMAN PHARMACEUTICALS INC (2)
Sienna Biopharmaceuticals, Inc. (2)
SIGA TECHNOLOGIES INC (5)
Sirtris Pharmaceuticals, Inc. (1)
Sonoma Pharmaceuticals, Inc. (10)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (5)
Supernus Pharmaceuticals, Inc. (10)
TAPESTRY PHARMACEUTICALS, INC (1)
Targeted Medical Pharma, Inc. (1)
Tarsus Pharmaceuticals, Inc. (2)
TAURIGA SCIENCES, INC. (1)
Telomir Pharmaceuticals, Inc. (1)
Terns Pharmaceuticals, Inc. (3)
Terra Tech Corp. (1)
TETRAGENEX PHARMACEUTICALS, INC. (1)
TETRALOGIC PHARMACEUTICALS CORP (1)
TETRAPHASE PHARMACEUTICALS INC (5)
TFF Pharmaceuticals, Inc. (1)
THAR PHARMACEUTICALS INC (1)
The Medicines Company (4)
TherapeuticsMD, Inc. (4)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (3)
Trevi Therapeutics, Inc. (1)
Tricida, Inc. (4)
United Cannabis Corp (1)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (1)
Valera Pharmaceuticals Inc (3)
Vallon Pharmaceuticals, Inc. (2)
Ventyx Biosciences, Inc. (4)
Verona Pharma plc (3)
Verrica Pharmaceuticals Inc. (4)
Viamet Pharmaceuticals Holdings LLC (1)
Vireo Health International, Inc. (7)
Vitae Pharmaceuticals, Inc (1)
Vitality Biopharma, Inc. (3)
VIVUS INC (6)
Wave Life Sciences Ltd. (8)
XANODYNE PHARMACEUTICALS INC (1)
XERIS PHARMACEUTICALS INC (2)
ZOGENIX, INC. (2)
Zomedica Pharmaceuticals Corp. (10)
Zynerba Pharmaceuticals, Inc. (5)

Recent Contracts

Second Amendment to Westinghouse Blvd. Lease effective November 26, 2024 (Level Brands, Inc., Filed With SEC on November 27, 2024)
Lease Agreement entered into as of November 15, 2024 by and between 1101 Technology Drive, L.L.C. and Zomedica Inc (Zomedica Pharmaceuticals Corp., Filed With SEC on November 19, 2024)
Sixteenth Amendment to Lease dated July 8, 2024 between Omeros Corporation and BMR-201 Elliott Avenue LLC (OMEROS CORP, Filed With SEC on November 13, 2024)
Lease Agreement, dated as of September 17, 2024, by and between ES 432-434 Industrial, LLC as Landlord and F.H. Investments, Inc. d/b/a Asteria Health as Tenant (Haymaker Acquisition Corp. III, Filed With SEC on November 12, 2024)
Seventh Amendment to Standard Office Lease, dated October 16, 2024, by and between the Company and SB Corporate Centre III-IV, LLC (Evoke Pharma Inc, Filed With SEC on November 7, 2024)
First Amendment to Northbridge Lease, dated September 30, 2024, by and between EyePoint Pharmaceuticals US, Inc. and 600 CPK LLC (EyePoint Pharmaceuticals, Inc., Filed With SEC on November 7, 2024)
Agreement of Lease by and between Loops Nursery & Greenhouses, Inc., a Florida corporation and Family Trust Created Under the Ruth F. Loop Revocable Trust Dated November 1, 1991,... (Planet 13 Holdings Inc., Filed With SEC on August 8, 2024)
Fifteenth Amendment to Lease dated November 1, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC (OMEROS CORP, Filed With SEC on August 7, 2024)
Eighth Amendment to Lease Agreement, dated April 1, 2024, by and between IIP-NY 2 LLC and Vireo Health of New York LLC (Vireo Health International, Inc., Filed With SEC on August 6, 2024)
Tenth Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of May 13, 2024 (Corcept Therapeutics Incorporated, Filed With SEC on July 29, 2024)
First Amendment to Office Lease dated July 1, 2024 (Terns Pharmaceuticals, Inc., Filed With SEC on July 3, 2024)
Suite 504 Lease Agreement, by and between the Company and Bridgeway, effective January 1, 2024 (LIPELLA PHARMACEUTICALS INC, Filed With SEC on May 9, 2024)
Seventh Amendment to Lease Agreement, dated March 11, 2024, by and between IIP-NY 2 LLC and Vireo Health of New York LLC (Vireo Health International, Inc., Filed With SEC on May 7, 2024)
Sixth Amendment to Lease Agreement, dated March 5, 2024, by and between IIP-NY 2 LLC and Vireo Health of New York LLC (Vireo Health International, Inc., Filed With SEC on May 7, 2024)
BASK Mutual Lease Modification Agreement dated May 3, 2024 (AmeriCann, Inc., Filed With SEC on May 7, 2024)
Sublease by and between Zuora, Inc. and Corcept Therapeutics Incorporated, entered into as of April 12, 2024 (Corcept Therapeutics Incorporated, Filed With SEC on May 1, 2024)
th Amendment to Office Lease Agreement by and between Exponent Realty, LLC and Corcept Therapeutics Incorporated, made and entered into as of (Corcept Therapeutics Incorporated, Filed With SEC on May 1, 2024)
Fifth Amendment to Lease Agreement, dated October 27, 2023, by and between IIP-NY 2 LLC and Vireo Health of New York, LLC (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Office Lease for Third Floor of the Companys Principal Executive Office Dated June 5, 2023 (CHINA PHARMA HOLDINGS, INC., Filed With SEC on April 1, 2024)
Office Lease for Second Floor of the Companys Principal Executive Office Dated June 5, 2023 (CHINA PHARMA HOLDINGS, INC., Filed With SEC on April 1, 2024)
Lease Agreement, by and between La Jolla Shores Plaza, LLC and GRI Bio Operations, Inc., dated as of March 2, 2018, for that property located at 2223 Avenida de la Playa, Suite... (Vallon Pharmaceuticals, Inc., Filed With SEC on March 28, 2024)
Sublease dated as of December 21, 2023, by and between RVAC Medicines (US), Inc. and Lyra Therapeutics, Inc (Lyra Therapeutics, Inc., Filed With SEC on March 22, 2024)
Lease Forbearance Agreement, dated as of March 14, 2024, by and between cbdMD, Inc. and HSKL, Inc (Level Brands, Inc., Filed With SEC on March 18, 2024)
Agreement of Sublease, dated December 1, 2023, between CymaBay Therapeutics, Inc. and Meta Platforms, Inc (CymaBay Therapeutics, Inc., Filed With SEC on February 28, 2024)
Second Amendment to Lease, dated February 6, 2024, between CymaBay Therapeutics, Inc. and BMR-Pacific Research Center, LP (CymaBay Therapeutics, Inc., Filed With SEC on February 28, 2024)
Agreement for Shared Lease Costs, dated April 1, 2023, between Telomir Pharmaceuticals, Inc., MIRALOGX LLC, and MIRA Pharmaceuticals, Inc (Telomir Pharmaceuticals, Inc., Filed With SEC on December 14, 2023)
Second Amendment to 200 Pine Street Office Lease, dated October 25, 2023, between Jaguar Health, Inc. and M & E, LLC (Jaguar Health, Inc., Filed With SEC on December 1, 2023)
First Amendment to 200 Pine Street Office Lease, dated December 24, 2021, between Jaguar Health, Inc. and M & E, LLC (Jaguar Health, Inc., Filed With SEC on December 1, 2023)
Sixth amendment to Lease between the Company and De Anza Enterprises LLC dated as of September 6, 2023 (DURECT CORP, Filed With SEC on November 14, 2023)
First Amendment to the Lease between the Company and Westland Development Services, Inc, dated June 21, 2023 (Sonoma Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
Boulder Lease Agreement between the Company and Westland Development Services, Inc., dated February 19, 2021 (Sonoma Pharmaceuticals, Inc., Filed With SEC on November 13, 2023)
Notice of Lease Terms, effective as of July 26, 2023, between the Registrant and BSP Senita 8000 Jarvis, LLC (Rain Therapeutics Inc., Filed With SEC on November 9, 2023)
Sixth Amendment to Standard Office Lease dated October 9, 2023, between the Company and SB Corporate Center III-IV, LLC (Evoke Pharma Inc, Filed With SEC on November 9, 2023)
Standard Industrial/Commercial Multi-Tenant Lease Net, by and between Rani Therapeutics, LLC and BKM South Bay 240, LLC, dated as of November 1, 2023 (Rani Therapeutics Holdings, Inc., Filed With SEC on November 8, 2023)
FOURTH AMENDMENT TO LEASE (resTORbio, Inc., Filed With SEC on November 8, 2023)
Sixth Amendment to Lease dated August 14, 2013, between Riverside Business Green, LP and Neos Therapeutics, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
Fifth Amendment to Lease dated April 5, 2010, between TIAA and Neos Therapeutics, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
Fourth Amendment to Lease dated May 1, 2009, between TIAA and Neos Therapeutics, LP (formerly PFAB, LP) (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
Third Amendment to Lease dated October 1, 2003, Between TIAA and PFAB, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)
Second Amendment to Lease dated September 4, 2003, between Teachers Insurance and Annuity Association of America and PFAB, LP (AYTU BIOSCIENCE, INC, Filed With SEC on October 12, 2023)